Upgrade to SI Premium - Free Trial

Akero Therapeutics (AKRO)

54.74 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (5/13/26 *Est.)

Latest Headlines

NextCure and Avere to merge, targeting oral IL-23 therapy July 14, 2026 6:01 AM - StreetInsider NextCure and Avere Therapeutics Announce Merger to Advance Once-Weekly Oral IL-23 Therapy July 14, 2026 6:00 AM - StreetInsider Full Article List